KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Depreciation and Depletion: 2013

Historic Depreciation and Depletion for Novavax (NVAX) over the last 1 years, with Dec 2013 value amounting to $200,000.

  • Novavax's Depreciation and Depletion was N/A to $297,000 in Q3 2009 from the same period last year, while for Sep 2009 it was $318,893, marking a year-over-year change of. This contributed to the annual value of $200,000 for FY2013, which is N/A change from last year.
  • Per Novavax's latest filing, its Depreciation and Depletion stood at $200,000 for FY2013.
  • Novavax's Depreciation and Depletion's 5-year high stood at $200,000 during FY2013, with a 5-year trough of $200,000 in FY2013.
  • Over the past 1 years, Novavax's median Depreciation and Depletion value was $200,000 (recorded in 2013), while the average stood at $200,000.